Related Experiment Videos
[Splenectomy: surgical indications in malignant hematologic diseases]
Langenbecks Archiv Fur Chirurgie
|January 1, 1986
Summary
Splenectomy is a surgical option for malignant hematological diseases to alleviate symptoms, aid in staging, and improve survival. Its utility is evaluated across various conditions, including lymphomas and leukemias.
Area of Science:
- Hematology
- Surgical Oncology
Context:
- Splenectomy is a surgical procedure involving the removal of the spleen.
- Malignant hematological diseases encompass a range of blood cancers affecting the lymphatic system and bone marrow.
Purpose:
- To discuss the indications for splenectomy in various malignant hematological diseases.
- To evaluate the role of splenectomy in symptom management, disease staging, and survival improvement.
Summary:
- Splenectomy is indicated in malignant hematological diseases for symptom relief, such as reducing splenomegaly and correcting cytopenias.
- The procedure plays a role in staging for Hodgkin lymphoma and improving survival in hairy cell leukemia.
- Its utility is also assessed in Non-Hodgkin lymphomas, chronic lymphatic leukemia, myelofibrosis, and chronic myeloid leukemia.
Impact:
- Provides insights into the therapeutic applications of splenectomy in hematologic oncology.
- Helps clinicians in decision-making regarding splenectomy for specific hematological conditions.
- Contributes to understanding spleen's role in the natural history and management of blood cancers.